Annual EBITDA
-$1.12 B
+$603.33 M+35.01%
31 December 2023
Summary:
BeiGene annual earnings before interest, taxes, depreciation & amortization is currently -$1.12 billion, with the most recent change of +$603.33 million (+35.01%) on 31 December 2023. During the last 3 years, it has risen by +$505.83 million (+31.11%). BGNE annual EBITDA is now -35491.39% below its all-time high of -$3.15 million, reached on 31 December 2013.BGNE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$48.97 M
+$33.26 M+40.44%
30 September 2024
Summary:
BeiGene quarterly earnings before interest, taxes, depreciation & amortization is currently -$48.97 million, with the most recent change of +$33.26 million (+40.44%) on 30 September 2024. Over the past year, it has increased by +$63.48 million (+56.45%). BGNE quarterly EBITDA is now -142.14% below its all-time high of $116.20 million, reached on 30 September 2017.BGNE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$727.23 M
+$63.48 M+8.03%
30 September 2024
Summary:
BeiGene TTM earnings before interest, taxes, depreciation & amortization is currently -$727.23 million, with the most recent change of +$63.48 million (+8.03%) on 30 September 2024. Over the past year, it has increased by +$483.46 million (+39.93%). BGNE TTM EBITDA is now -9100.84% below its all-time high of -$7.90 million, reached on 30 September 2014.BGNE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGNE EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.0% | +56.5% | +39.9% |
| 3 y3 years | +31.1% | +89.1% | +44.5% |
| 5 y5 years | -61.1% | +84.1% | +13.2% |
BGNE EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.0% | at high | +91.2% | at high | +61.7% |
| 5 y | 5 years | -61.1% | +35.0% | -161.4% | +91.2% | at high | +61.7% |
| alltime | all time | <-9999.0% | +35.0% | -142.1% | +91.2% | -9100.8% | +61.7% |
BeiGene EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$48.97 M(-40.4%) | -$727.23 M(-8.0%) |
| June 2024 | - | -$82.23 M(-65.2%) | -$790.72 M(-21.3%) |
| Mar 2024 | - | -$236.06 M(-34.4%) | -$1.00 B(-10.3%) |
| Dec 2023 | -$1.12 B(-35.0%) | -$359.98 M(+220.1%) | -$1.12 B(-7.5%) |
| Sept 2023 | - | -$112.46 M(-62.1%) | -$1.21 B(-20.4%) |
| June 2023 | - | -$296.38 M(-15.6%) | -$1.52 B(-7.7%) |
| Mar 2023 | - | -$351.25 M(-22.1%) | -$1.65 B(-4.4%) |
| Dec 2022 | -$1.72 B(+23.8%) | -$450.61 M(+6.7%) | -$1.72 B(-5.9%) |
| Sept 2022 | - | -$422.16 M(-0.4%) | -$1.83 B(-1.5%) |
| June 2022 | - | -$423.94 M(-0.6%) | -$1.86 B(-2.1%) |
| Mar 2022 | - | -$426.69 M(-23.6%) | -$1.90 B(+36.4%) |
| Dec 2021 | -$1.39 B(-14.4%) | -$558.62 M(+24.1%) | -$1.39 B(+6.2%) |
| Sept 2021 | - | -$450.15 M(-2.8%) | -$1.31 B(+1.4%) |
| June 2021 | - | -$463.31 M(-680.6%) | -$1.29 B(+9.5%) |
| Mar 2021 | - | $79.80 M(-116.7%) | -$1.18 B(-27.4%) |
| Dec 2020 | -$1.63 B(+72.7%) | -$477.08 M(+10.5%) | -$1.63 B(+6.3%) |
| Sept 2020 | - | -$431.79 M(+23.0%) | -$1.53 B(+8.8%) |
| June 2020 | - | -$351.01 M(-4.1%) | -$1.41 B(+23.6%) |
| Mar 2020 | - | -$366.01 M(-3.8%) | -$1.14 B(+20.8%) |
| Dec 2019 | -$941.27 M | -$380.55 M(+23.5%) | -$941.27 M(+12.3%) |
| Sept 2019 | - | -$308.24 M(+275.3%) | -$838.17 M(+23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$82.14 M(-51.8%) | -$678.58 M(-10.4%) |
| Mar 2019 | - | -$170.34 M(-38.6%) | -$757.15 M(+8.9%) |
| Dec 2018 | -$695.38 M(+642.1%) | -$277.44 M(+86.6%) | -$695.38 M(+33.8%) |
| Sept 2018 | - | -$148.66 M(-7.5%) | -$519.68 M(+103.9%) |
| June 2018 | - | -$160.71 M(+48.0%) | -$254.82 M(+68.1%) |
| Mar 2018 | - | -$108.56 M(+6.7%) | -$151.59 M(+61.8%) |
| Dec 2017 | -$93.70 M(-18.6%) | -$101.74 M(-187.6%) | -$93.70 M(+225.9%) |
| Sept 2017 | - | $116.20 M(-302.2%) | -$28.75 M(-84.0%) |
| June 2017 | - | -$57.48 M(+13.4%) | -$179.28 M(+22.9%) |
| Mar 2017 | - | -$50.68 M(+37.7%) | -$145.93 M(+26.7%) |
| Dec 2016 | -$115.15 M(+108.6%) | -$36.80 M(+7.2%) | -$115.15 M(+9.0%) |
| Sept 2016 | - | -$34.32 M(+42.2%) | -$105.67 M(+24.8%) |
| June 2016 | - | -$24.14 M(+21.3%) | -$84.64 M(+29.2%) |
| Mar 2016 | - | -$19.89 M(-27.2%) | -$65.50 M(+18.7%) |
| Dec 2015 | -$55.20 M(+288.7%) | -$27.32 M(+105.4%) | -$55.20 M(+74.1%) |
| Sept 2015 | - | -$13.30 M(+166.2%) | -$31.70 M(+20.5%) |
| June 2015 | - | -$5.00 M(-47.9%) | -$26.31 M(+23.4%) |
| Mar 2015 | - | -$9.59 M(+151.5%) | -$21.31 M(+81.9%) |
| Dec 2014 | -$14.20 M(+351.2%) | -$3.81 M(-51.7%) | -$11.72 M(+48.3%) |
| Sept 2014 | - | -$7.90 M | -$7.90 M |
| Dec 2013 | -$3.15 M | - | - |
FAQ
- What is BeiGene annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for BeiGene?
- What is BeiGene annual EBITDA year-on-year change?
- What is BeiGene quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for BeiGene?
- What is BeiGene quarterly EBITDA year-on-year change?
- What is BeiGene TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for BeiGene?
- What is BeiGene TTM EBITDA year-on-year change?
What is BeiGene annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of BGNE is -$1.12 B
What is the all time high annual EBITDA for BeiGene?
BeiGene all-time high annual earnings before interest, taxes, depreciation & amortization is -$3.15 M
What is BeiGene annual EBITDA year-on-year change?
Over the past year, BGNE annual earnings before interest, taxes, depreciation & amortization has changed by +$603.33 M (+35.01%)
What is BeiGene quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of BGNE is -$48.97 M
What is the all time high quarterly EBITDA for BeiGene?
BeiGene all-time high quarterly earnings before interest, taxes, depreciation & amortization is $116.20 M
What is BeiGene quarterly EBITDA year-on-year change?
Over the past year, BGNE quarterly earnings before interest, taxes, depreciation & amortization has changed by +$63.48 M (+56.45%)
What is BeiGene TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of BGNE is -$727.23 M
What is the all time high TTM EBITDA for BeiGene?
BeiGene all-time high TTM earnings before interest, taxes, depreciation & amortization is -$7.90 M
What is BeiGene TTM EBITDA year-on-year change?
Over the past year, BGNE TTM earnings before interest, taxes, depreciation & amortization has changed by +$483.46 M (+39.93%)